Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 5 November 2014, 08:16 HKT/SGT
Share:
    

Source: China Pioneer Pharma Holdings Limited
China Pioneer Pharma Expands NeutroPhase Marketing in Taiwan

HONG KONG, Nov 5, 2014 - (ACN Newswire) - China Pioneer Pharma Holdings Limited, the leading comprehensive marketing, promotion and channel management service providers dedicated to imported pharmaceutical products and medical devices in China, today announced Taiwan's Food and Drug Administration has approved the launch of NovaBay Pharmaceuticals, Inc.'s medical devices product NeutroPhase Skin and Wound Cleanser for sale in Taiwan. China Pioneer Pharma will launch NeutroPhase in Taiwan in early 2015. NeutroPhase previously has been approved for sale throughout mainland China, Singapore, Malaysia and the United States. China Pioneer Pharma owns about 15% of NovaBay's shares, making it NovaBay's largest shareholder, and is also the exclusive distributor for NeutroPhase in mainland China and throughout Southeast Asia.

NeutroPhase contains Neutrox(TM), NovaBay's proprietary, manufactured pure hypochlorous acid solution which mimics a substance produced naturally by the immune system as a first defense against microbial invaders. Laboratory tests show that Neutrox not only kills bacteria that infect wounds and cause necrotizing fasciitis, it also neutralizes toxins produced by both bacteria and the immune system that impede healing and destroy healthy tissue. Those properties enable NeutroPhase to be useful as an advanced wound cleanser in the management of acute and chronic infections, allowing the body to progress toward healing.

Mr. LI Xinzhou, Chairman, Executive Director and Chief Executive Officer of China Pioneer Pharma said, "China Pioneer Pharma will be working with local distributers to sell NeutroPhase products in Taiwan. We believe that NeutroPhase can bring a major improvement in medical care. This will help address major unmet medical needs to more physicians and patients, bring them a new tool in managing chronic non-healing wounds, such as diabetic ulcers, and in treating acute infections like flesh-eating disease."


Topic: Press release summary
Source: China Pioneer Pharma Holdings Limited

Sectors: Daily Finance, Daily News, Healthcare & Pharm
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



China Pioneer Pharma Holdings Limited
Mar 30, 2016 12:52 HKT/SGT
China Pioneer Pharma Announces Annual Results for Year Ended 31 December 2015
Mar 10, 2016 18:00 HKT/SGT
UNITY Balloon Expandable Bioresorbable Hybrid Biliary/Peripheral Vascular Stent Implanted for the 1st Time in Southeast Asia; China Pioneer Pharma is the Distributor
Feb 25, 2016 11:52 HKT/SGT
China Pioneer Pharma Extended the Rights to Market, Promote and Sell Polimod in China
Aug 26, 2015 08:54 HKT/SGT
China Pioneer Pharma Announces Interim Results for the Six Months Ended 30 June 2015
Aug 14, 2015 12:34 HKT/SGT
China Pioneer Pharma Offers Free NeutroPhase to Victims Suffered Burns in the Explosion in Tianjin
July 10, 2015 20:44 HKT/SGT
China Pioneer Pharma Invited American Wound Care Expert to Provide Medical Advices for the Burn Victims in Taiwan's Dust Explosion
June 29, 2015 23:16 HKT/SGT
China Pioneer Pharma Offers Free NeutroPhase to Victims Suffered Burns in the Dust Explosion in Taiwan
Apr 1, 2015 18:43 HKT/SGT
NeutroPhase Was Named as the Official Wound Cleanser of the NNFF
Dec 21, 2014 21:09 HKT/SGT
China Pioneer Pharma Extended the Rights to Market, Promote and Sell Polimod, Macmiror Complex and Macmiror, and Granted the Rights to Market, Promote and Sell a new product Cripar
Dec 16, 2014 19:40 HKT/SGT
China Pioneer Pharma Joins Hand with NovaBay Pharmaceuticals and the NNFF To Offer Free New Life-Saving Treatment for "Flesh-Eating" Disease
More news >>
 News Alerts
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: